Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Girona-Llobera

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Transfusion|October 7, 2019
Use and safety of riboflavin and UV light-treated platelet transfusions in children over a five-year period: focusing on neonatesTeresa Jimenez-Marco, Marta Garcia-Recio, Enrique Girona-Llobera
Transfusion|August 23, 2018
Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient careTeresa Jimenez-Marco, Marta Garcia-Recio, Enrique Girona-Llobera
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 3, 2015
Practical issues that should be considered when planning the implementation of pathogen reduction technology for plateletpheresisTeresa Jimenez-Marco, Catalina Mercant, Esperanza Lliteras, et al.
Transfusion|June 21, 2016
Where do Trypanosoma cruzi go? The distribution of parasites in blood components from fractionated infected whole bloodBeatriz Cancino-Faure, Roser Fisa, Cristina Riera, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 24, 2014
Role of Riboflavin- and UV Light-Treated Plasma in Prevention of Transfusion-Related Acute Lung InjuryTeresa Jimenez-Marco, Daniel Ruiz-Alderton, Antonia M Bautista-Gili, et al.
Transfusion|February 17, 2015
Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donorsBeatriz Cancino-Faure, Roser Fisa, Cristina Riera, et al.
Transfusion|April 19, 2017
The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole bloodTeresa Jimenez-Marco, Beatriz Cancino-Faure, Enrique Girona-Llobera, et al.
Transfusion|May 10, 2013
Reducing the financial impact of pathogen inactivation technology for platelet components: our experienceEnrique Girona-Llobera, Teresa Jimenez-Marco, Ana Galmes-Trueba, et al.
Blood Transfusion = Trasfusione Del Sangue|June 13, 2020
Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV lightCarme Ballester-Servera, Teresa Jimenez-Marco, Daniel Morell-Garcia, et al.
Transfusion|March 11, 2021
Cryopreservation of platelets treated with riboflavin and UV light and stored at -80°C for 1 yearTeresa Jimenez-Marco, Carme Ballester-Servera, Miguel Quetglas-Oliver, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Transfusion|October 7, 2019
Use and safety of riboflavin and UV light-treated platelet transfusions in children over a five-year period: focusing on neonatesTeresa Jimenez-Marco, Marta Garcia-Recio, Enrique Girona-Llobera
Transfusion|August 23, 2018
Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient careTeresa Jimenez-Marco, Marta Garcia-Recio, Enrique Girona-Llobera
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 3, 2015
Practical issues that should be considered when planning the implementation of pathogen reduction technology for plateletpheresisTeresa Jimenez-Marco, Catalina Mercant, Esperanza Lliteras, et al.
Transfusion|June 21, 2016
Where do Trypanosoma cruzi go? The distribution of parasites in blood components from fractionated infected whole bloodBeatriz Cancino-Faure, Roser Fisa, Cristina Riera, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 24, 2014
Role of Riboflavin- and UV Light-Treated Plasma in Prevention of Transfusion-Related Acute Lung InjuryTeresa Jimenez-Marco, Daniel Ruiz-Alderton, Antonia M Bautista-Gili, et al.
Transfusion|February 17, 2015
Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donorsBeatriz Cancino-Faure, Roser Fisa, Cristina Riera, et al.
Transfusion|April 19, 2017
The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole bloodTeresa Jimenez-Marco, Beatriz Cancino-Faure, Enrique Girona-Llobera, et al.
Transfusion|May 10, 2013
Reducing the financial impact of pathogen inactivation technology for platelet components: our experienceEnrique Girona-Llobera, Teresa Jimenez-Marco, Ana Galmes-Trueba, et al.
Blood Transfusion = Trasfusione Del Sangue|June 13, 2020
Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV lightCarme Ballester-Servera, Teresa Jimenez-Marco, Daniel Morell-Garcia, et al.
Transfusion|March 11, 2021
Cryopreservation of platelets treated with riboflavin and UV light and stored at -80°C for 1 yearTeresa Jimenez-Marco, Carme Ballester-Servera, Miguel Quetglas-Oliver, et al.
Pageof 2